搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
6 天
首个!强生潜在重磅疗法2/3期试验积极结果公布
强生(Johnson & ...
搜狐
6 天
重组HEL D1.3同型对照抗体,雪貂IgM,体内实验级
在克隆号HEL D1.3中获得的重组抗-HEL同型对照抗体和Fc silenced突变体(Recombinant anti-HEL isotype control antibodies and Fc silenced mutants)适用于体外和体内研究。与经测试的人,小鼠和大鼠样本的特异性结合程度低或无特异性结合。“人性化”是指可变区域的人性化。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Arizona official pleads guilty
Loan payment pause extended
Meteorite aided early life?
Copyright infringement suit
1st trans lawyer at SCOTUS
Crew ID’d in WA jet crash
University protest arrests
Washington state shooting
AR marijuana votes blocked
China holds live-fire drills
Weinstein's cancer diagnosis
Chicago named 'rattiest city'
Stroke prevention guidance
GA county to sue BioLab
$400M aid package for UKR
US data protection move
Sued by Murdoch’s firms
Bacteria cases rise in FL
Overseas ballot suits denied
Early voting in Wisconsin
Union opts out of CBA
NC tops 1 million votes
Ex-Iron Maiden singer dies
Peru ex-president sentenced
Bitcoin nears $70,000
Judge weighs Louisiana law
AU, US $4.7B missile deal
Tours Helene storm damage
Had multiple drugs in body?
Minks released, 2 arrested
Out with ruptured Achilles
To get up to $325M grant
Files suit over fake drugs
反馈